Related Experiment Video
Updated: May 29, 2026

Assays for the Specific Growth Rate and Cell-binding Ability of Rotavirus
Published on: January 28, 2019
Inhibitory effects of bile acids and synthetic farnesoid X receptor agonists on rotavirus replication
Yunjeong Kim1, Kyeong-Ok Chang
1Department of Diagnostic Medicine and Pathobiology, College of Veterinary Medicine, Kansas State University, 1800 Denison Avenue, Manhattan, KS 66506, USA. ykim@vet.ksu.edu
Abstract:
Rotaviruses (group A rotaviruses) are the most important cause of severe gastroenteritis in infants and children worldwide. Currently, an antiviral drug is not available and information on therapeutic targets for antiviral development is limited for rotavirus infection. Previously, it was shown that lipid homeostasis is important in rotavirus replication. Since farnesoid X receptor (FXR) and its natural ligands bile acids (such as chenodeoxycholic acid [CDCA]) play major roles in cholesterol and lipid homeostasis, we examined the effects of bile acids and synthetic FXR agonists on rotavirus replication in association with cellular lipid levels. In a mouse model of rotavirus infection, effects of oral administration of CDCA on fecal rotavirus shedding were investigated. The results demonstrate the following. First, the intracellular contents of triglycerides were significantly increased by rotavirus infection. Second, CDCA, deoxycholic acid (DCA), and other synthetic FXR agonists, such as GW4064, significantly reduced rotavirus replication in cell culture in a dose-dependent manner. The reduction of virus replication correlated positively with activation of the FXR pathway and reduction of cellular triglyceride contents (r(2) = 0.95). Third, oral administration of CDCA significantly reduced fecal virus shedding in mice (P < 0.05). We conclude that bile acids and FXR agonists play important roles in the suppression of rotavirus replication. The inhibition mechanism is proposed to be the downregulation of lipid synthesis induced by rotavirus infection.
Insights
Bile acids and farnesoid X receptor (FXR) agonists reduce rotavirus replication by regulating lipid synthesis. This study shows potential therapeutic targets for developing new antiviral drugs against rotavirus infection.
Area of Science:
- Virology
- Biochemistry
- Pharmacology
Background:
- Rotaviruses cause severe gastroenteritis in children globally.
- No specific antiviral drugs are currently available for rotavirus infection.
- Lipid homeostasis is crucial for rotavirus replication.
Purpose of the Study:
- To investigate the effect of bile acids and farnesoid X receptor (FXR) agonists on rotavirus replication.
- To explore the association between cellular lipid levels and rotavirus replication.
- To evaluate the therapeutic potential of FXR agonists against rotavirus infection.
Main Methods:
- Cell culture experiments to assess rotavirus replication.
- Treatment with bile acids (CDCA, DCA) and synthetic FXR agonists (GW4064).
- Measurement of intracellular triglyceride levels.
- In vivo study using a mouse model of rotavirus infection.
Main Results:
- Rotavirus infection significantly increased intracellular triglyceride levels.
- CDCA, DCA, and GW4064 dose-dependently reduced rotavirus replication in cell culture.
- Reduced viral replication correlated with FXR pathway activation and decreased triglyceride levels (r(2) = 0.95).
- Oral CDCA administration significantly reduced fecal rotavirus shedding in mice.
Conclusions:
- Bile acids and FXR agonists effectively suppress rotavirus replication.
- The mechanism involves downregulating lipid synthesis pathways disrupted by rotavirus infection.
- FXR agonists represent promising therapeutic targets for rotavirus antiviral development.
Related Concept Videos
Inhibitors of Viral Protein Synthesis
Inhibitors Of Virion Release
Respiratory Syncytial Virus Disease
Inhibitors of Bacterial DNA Synthesis
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents
Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents
Adsorbents...

